AzTrials
AzTrials

Condition

Heart Failure Clinical Trials

Studies of heart failure, matched by condition name and medical subject headings. Start with those open to enrolment.

In numbers

Open to volunteers
1,345
Active
1,592

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 1,345
  • Heart Failure, Heart Failure With Preserved Ejection Fraction

    Assessment of CCM in HF With Higher Ejection Fraction

    • Recruiting
    • Age: 18 years and older
    • Medical device

    The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.

    Conditions
    Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Heart Failure With Moderately Reduced Ejection Fraction
    Trial name
    AIM HIGHer (NCT05064709)
    Testing
    Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System, OPTIMIZER™ Smart Mini System
    Where
    67 sites in United States
    Volunteers
    1,500 people
    Sponsor
    Impulse Dynamics
    Can I take part? AIM HIGHer
  • Pulmonary Edema, Congestive Heart Failure

    DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure

    • Recruiting
    • Age: 18 years and older
    • Phase 4
    • Injection or infusion

    DECONGEST-AHF compares three initial treatments for adults admitted with suspected pulmonary congestion due to acute heart failure: intravenous furosemide, intravenous isosorbide dinitrate, or both medicines together.

    Conditions
    Pulmonary Edema, Congestive Heart Failure, Acute Heart Failure
    Trial name
    DECONGEST-AHF (NCT05276219)
    Testing
    Furosemide Injection, Isosorbide Dinitrate, Furosemide and isosorbide dinitrate
    Where
    5 sites in Denmark
    Volunteers
    1,041 people
    Sponsor
    Copenhagen University Hospital, Rigshospitalet
  • Heart Failure

    Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

    • Enrolling by invitation
    • Age: 18 to 100 years
    • Observational study

    Background: More than 6.5 million people in the United States live with heart failure (HF), and more than a million new cases are diagnosed each year.

    Trial name
    NCT06280820
    Where
    2 sites in United States
    Volunteers
    2,000 people
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Can I take part? NCT06280820
  • Heart Failure With Reduced Ejection Fraction

    Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

    • Recruiting
    • Age: 18 years and older
    • Medical device

    RECOVER HF is a clinical study designed to evaluate the safety and efficacy of Synchronized Diaphragmatic Stimulation delivered using the VisONE System in the treatment of patients with heart failure.

    Trial name
    RECOVER-HF (NCT06552637)
    Testing
    Synchronized Diaphragmatic Stimulation
    Where
    5 sites in United States, Georgia
    Volunteers
    270 people
    Sponsor
    VisCardia Inc.
    Can I take part? RECOVER-HF
  • Heart Failure

    A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

    • Recruiting
    • Age: 18 to 79 years
    • Phase 2

    The purpose of this study is to learn about the safety and effects of the study medicine (PF-07328948) for the possible treatment of heart failure (HF).

    Trial name
    NCT06991257
    Testing
    Low Dose PF-07328948, Medium Dose PF-07328948, High Dose PF-07328948
    Where
    150 sites in United States, Argentina and 12 more
    Volunteers
    620 people
    Sponsor
    Pfizer
    Can I take part? NCT06991257
  • Cardiac Pacing, Cardiac Pacemaker

    BIO|STREAM.CSP Study

    • Recruiting
    • Age: 18 years and older
    • Observational study
    • Medical device

    The registry is designed to assess outcome, performance and residual safety aspects of BIOTRONIK products which are used in the context of CSP based on long-term data from an unselected, real-life clinical set-up.

    Conditions
    Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices
    Trial name
    NCT07393009
    Testing
    Implantation of the Solia CSP S pacing lead for LBBAP
    Where
    46 sites in Australia, Austria and 11 more
    Volunteers
    1,000 people
    Sponsor
    Biotronik SE & Co. KG
    Can I take part? NCT07393009
  • Cardiogenic Shock, Acute Myocardial Infarction of Inferior Wall

    Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support

    • Recruiting
    • Age: 19 years and older
    • Surgery or procedure

    A prospective, multi-center, open label, randomized controlled, superiority trial to compare clinical outcomes between routine distal perfusion catheter (DPC) insertion versus provisional distal perfusion catheter (DPC) insertion…

    Conditions
    Cardiogenic Shock, Acute Myocardial Infarction of Inferior Wall, Congestive Heart Failure, Myocarditis
    Trial name
    PERFUSE-MCS (NCT07482865)
    Testing
    Distal perfusion catheter insertion
    Where
    6 sites in South Korea
    Volunteers
    500 people
    Sponsor
    Samsung Medical Center
    Can I take part? PERFUSE-MCS
  • Right Ventricular Function, Prone Position

    Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine

    • Not yet recruiting
    • Age: 18 years and older
    • Surgery or procedure

    Right ventricular failure (RVF) is a common complication to cardiac surgery, which is associated to mortality, kidney failure, stroke, prolonged mechanical ventilation and ICU stay.

    Conditions
    Right Ventricular Function, Prone Position, Atelectasis, Atelectases, Postoperative Pulmonary
    Trial name
    BAROLO (NCT07632027)
    Testing
    Prone position
    Where
    Sweden
    Volunteers
    70 people
    Sponsor
    Sahlgrenska University Hospital
    Can I take part? BAROLO
  • Heart Failure

    Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

    • Recruiting
    • Age: 18 to 80 years
    • Phase 3
    • Pill or oral medicine

    This trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted from Coronary Heart Disease (Syndrome of Qi Deficiency with Blood…

    Trial name
    NCT07687186
    Testing
    Qishen Yiqi Dripping Pills 2 bags
    Where
    60 sites in China
    Volunteers
    636 people
    Sponsor
    Tasly Pharmaceutical Group Co., Ltd
    Can I take part? NCT07687186
  • Heart Failure

    Mobile Health Intervention to Increase Activity in Heart Failure Study

    • Recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    Physical activity is known to help patients with heart failure feel better and live longer though few patients with heart failure are sufficiently active.

    Trial name
    MOVIN-HF (NCT07750262)
    Testing
    Mobile application intervention
    Where
    United States
    Volunteers
    50 people
    Sponsor
    University of Michigan
    Can I take part? MOVIN-HF

Completed, with results posted

All –
  • Chronic Disease, Frail

    Functional Exercise and Nutrition Education Program for Older Adults

    • Completed
    • Age: 60 years and older
    • Results posted

    There is strong evidence that specific types of exercise can improve health and physical function in older adults. While community exercise classes exist, many older adults with chronic conditions may need guidance from…

    Conditions
    Chronic Disease, Frail, Diabetes Mellitus, Cancer
    Trial name
    MoveStrong (NCT04037436)
    Testing
    Strength and Balance Training & Nutrition Education, Usual Care
    Where
    5 sites in Canada
    Volunteers
    44 people
    Sponsor
    University of Waterloo
    Can I take part? MoveStrong
  • Chronic Heart Failure

    Acupuncture on Cardiac and Autonomic Function in Human Heart Failure

    • Completed
    • Age: 21 years and older
    • Surgery or procedure
    • Results posted

    Acupuncture treatment may improve the cardiac function and the quality of life in heart failure patients. These effects may be related to the inhibition of sympathetic activity and/or increased vagal function.

    Trial name
    NCT01804816
    Testing
    Acupuncture, No Intervention
    Where
    United States
    Volunteers
    14 people
    Sponsor
    The Cleveland Clinic
    Can I take part? NCT01804816
  • HIV/AIDS, Heart Failure With Preserved Ejection Fraction

    The ENCHANTMENT HIV Study

    • Completed
    • Age: 40 to 70 years
    • Phase 2
    • Pill or oral medicine
    • Results posted

    Persons with HIV, even those well-treated, are at increased risk for heart disease when compared to the general population. Two hormones called aldosterone and brain natriuretic peptide (BNP), which have been shown to be abnormal…

    Trial name
    NCT04153136
    Testing
    Sacubitril-Valsartan 49-51Mg Oral Tablet
    Where
    United States
    Volunteers
    39 people
    Sponsor
    Massachusetts General Hospital
  • Heart Failure

    Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart Failure

    • Completed
    • Age: 40 years and older
    • Lifestyle or therapy programme
    • Results posted

    Approximately 6.5 million people have heart failure (HF) in the United States, and 960,000 new cases are reported each year. HF is one of the most common hospital diagnosis among older adults.

    Trial name
    iCardia4HF (NCT03642275)
    Testing
    iCardia4HF
    Where
    United States
    Volunteers
    27 people
    Sponsor
    University of Illinois at Chicago
    Can I take part? iCardia4HF
  • Heart Failure NYHA Class II, Heart Failure NYHA Class III

    Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure

    • Completed
    • Age: 18 to 90 years
    • Lifestyle or therapy programme
    • Results posted

    Individuals with chronic heart failure need a "safe and effective" exercise program that could enhance their quality of life. In this study, we examined whether an experimental exercise program of autonomous walking and…

    Trial name
    NCT01560871
    Testing
    High-intensity IMT plus walking, Low-intensity IMT plus walking
    Where
    2 sites in United States
    Volunteers
    16 people
    Sponsor
    Texas Woman's University
    Can I take part? NCT01560871

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in